OrbiMed’s Sonendo, Inc. SONX Stock Holding History

OrbiMed’s Portfolio SONX Stock Details SONX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-723,478	Closed	-$1.24M	–	148
2022 Q2	$1.24M	Sell	723,478 -1,244,702	-63%	-$3.32M	0.02%	138
2022 Q1	$7.89M	Hold	1,968,180	–	–	0.13%	109
2021 Q4	$11.3M	Buy	+1,968,180	New	+$17.7M	0.15%	113

Other funds holding SONX

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

MCAI

Meritech Capital Associates IV Palo Alto, California $51.9M AUM 64.09% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Yu Fan $108M AUM 137.54% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

OrbiMed's SONX Position: Q3 2022 in Review

OrbiMed sold out of Sonendo, Inc. (SONX) in Q3 2022, closing a stake of 723,478 shares — an estimated $1.24M sold.

OrbiMed first reported a position in SONX in Q4 2021 and held it in 3 quarters. The position peaked at $11.3M in Q4 2021. 40 funds tracked by Wall St. Rank hold SONX as of Q3 2022.

OrbiMed reported no remaining Sonendo, Inc. position as of Q3 2022 after selling out during the quarter.
OrbiMed sold 723,478 Sonendo, Inc. shares in Q3 2022, an estimated $1.24M.
OrbiMed first reported a position in Sonendo, Inc. in Q4 2021 and held it in 3 quarters.
OrbiMed's Sonendo, Inc. position peaked at $11.3M in Q4 2021.
40 funds tracked by Wall St. Rank held Sonendo, Inc. as of Q3 2022.

Based on OrbiMed's 13F filing for Q3 2022, filed 14 Nov 2022.